US drug approvals
49 approvals with a product on the US market
- Progesterone ANDA219588 · approved 16 Oct 2026
- Drospirenone And Estradiol ANDA218031 · approved 28 Oct 2025
- Conjugated Estrogens ANDA214023 · approved 15 Oct 2025
- Conjugated Estrogens ANDA214025 · approved 15 Oct 2025
- Diltiazem Hydrochloride ANDA218032 · approved 2 Jul 2025
Source: Drugs@FDA, Approvals (NDA, ANDA, BLA) held, with a product sold now; newest shown. Retrieved 13 Nov 2026.